# Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

> **NCT00004157** · PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center**

## Conditions studied

- Breast Cancer
- Gestational Trophoblastic Tumor
- Kidney Cancer
- Lymphoma
- Neuroblastoma
- Ovarian Cancer
- Sarcoma
- Testicular Germ Cell Tumor

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** recombinant interleukin-11

## Key facts

- **NCT ID:** NCT00004157
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08
- **Primary completion:** 2002-04
- **Final completion:** 2002-04
- **Target enrollment:** — (—)
- **Last updated:** 2010-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004157, "Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00004157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*